IJMS 2018 Publication on Drug-Resistance in TNBC

2018 Publication on Drug-Resistance in TNBC :

Triple-negative breast cancer (TNBC) is among the most notorious types of breast cancer, the treatment of which does not give consistent results due to the absence of the three receptors (estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) as well as high amount of molecular variability. Drug resistance also contributes to treatment unresponsiveness.

[Read More … ]

Leave a Reply

Your email address will not be published.

Name *
Email *
Website